The global programme to eliminate lymphatic filariasis: health impact after 8 years.
<h4>Background</h4>In its first 8 years, the Global Programme to Eliminate Lymphatic Filariasis (GPELF) achieved an unprecedentedly rapid scale-up: >1.9 billion treatments with anti-filarial drugs (albendazole, ivermectin, and diethylcarbamazine) were provided via yearly mass drug adm...
Main Authors: | Eric A Ottesen, Pamela J Hooper, Mark Bradley, Gautam Biswas |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-10-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18841205/?tool=EBI |
Similar Items
-
Assessing progress in reducing the at-risk population after 13 years of the global programme to eliminate lymphatic filariasis.
by: Pamela J Hooper, et al.
Published: (2014-11-01) -
The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).
by: Brian K Chu, et al.
Published: (2010-06-01) -
Global programme to eliminate lymphatic filariasis: the processes underlying programme success.
by: Kazuyo Ichimori, et al.
Published: (2014-12-01) -
Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease.
by: K D Ramaiah, et al.
Published: (2014-11-01) -
Global alliance for the elimination of lymphatic filariasis
by: S Das
Published: (2005-01-01)